v3.25.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Compensation  
Schedule of outstanding and exercisable options

2025

Weighted

Number

average

of shares

exercise

    

2019 Plan

   

Inducement Plan

2011 Plan

   

Total

   

price

Outstanding at beginning of period - 2011 Plan

 

    

1,632,485

    

1,632,485

    

$

2.11

Outstanding at beginning of period - 2019 Plan

7,604,606

7,604,606

4.97

Outstanding at beginning of period - Inducement Plan

496,000

496,000

5.99

Granted - 2019 Plan

1,151,400

1,151,400

2.02

Granted - Inducement Plan

244,000

244,000

2.01

Outstanding at end of period

 

8,756,006

740,000

1,632,485

11,128,491

$

4.22

Outstanding at end of period - Weighted average exercise price

$

4.58

$

4.68

$

2.11

Exercisable at end of period

5,795,146

350,292

1,632,485

7,777,923

$

4.85

Exercisable at end of period - Weighted average exercise price

 

$

5.54

$

6.22

$

2.11

2024

Weighted

Number

average

of shares

exercise

2019 Plan

   

Inducement Plan

2011 Plan

   

Total

   

price

Outstanding at beginning of period - 2011 Plan

    

1,694,233

1,694,233

$

2.09

Outstanding at beginning of period - 2019 Plan

 

6,406,897

6,406,897

5.82

Outstanding at beginning of period - Inducement Plan

625,000

625,000

5.74

Granted - 2019 Plan

45,000

45,000

1.45

Forfeited - Inducement Plan

(98,250)

(98,250)

4.33

Forfeited - 2019 Plan

(386,053)

(386,053)

4.42

Expired - 2019 Plan

(13,722)

(13,722)

6.36

Outstanding at end of period

6,052,122

526,750

1,694,233

8,273,105

$

5.11

Outstanding at end of period - Weighted average exercise price

$

5.88

$

6.00

$

2.09

Exercisable at end of period

3,819,413

250,271

1,694,233

5,763,917

$

5.24

Exercisable at end of period - Weighted average exercise price

$

6.56

6.42

$

2.09

Schedule of non-vested share options activity

2025

Number

Weighted

of options

average

2019 Plan

    

Inducement Plan

    

2011 Plan

    

Total

    

fair value

Non-vested share options at beginning of period - 2019 Plan

2,754,054

2,754,054

 

2.33

Non-vested share options at beginning of period - Inducement Plan

176,709

176,709

4.19

Granted - 2019 Plan

 

1,151,400

1,151,400

1.64

Granted - Inducement Plan

244,000

244,000

1.60

Vested, outstanding - 2019 Plan

(944,594)

(944,594)

2.12

Vested, outstanding - Inducement Plan

(31,001)

(31,001)

4.53

Non-vested share options at end of period

 

2,960,860

389,708

3,350,568

 

$

2.18

Non-vested share options at end of period - Weighted average fair value

$

2.13

$

2.54

$

2024

Number

Weighted

of options

average

    

2019 Plan

    

Inducement Plan

    

2011 Plan

    

Total

    

fair value

Non-vested share options at beginning of period - 2019 Plan

3,178,475

3,178,475

 

3.64

Non-vested share options at beginning of period - Inducement Plan

403,167

403,167

4.07

Granted - 2019 Plan

 

45,000

45,000

1.12

Vested, outstanding - 2019 Plan

(604,713)

(604,713)

3.54

Vested, outstanding - Inducement Plan

(28,438)

(28,438)

4.85

Forfeited - Inducement Plan

(98,250)

(98,250)

3.31

Forfeited - 2019 Plan

(386,053)

(386,053)

3.47

Non-vested share options at end of period

 

2,232,709

276,479

2,509,188.00

 

$

3.71

Non-vested share options at end of period - Weighted average fair value

$

3.64

$

$

Schedule of weighted average assumptions for the options granted

Three months ended March 31, 

2025

    

2024

 

Exercise price

$

2.02

 

$

1.45

Share price

$

2.02

 

$

1.45

Volatility

 

100

%  

91

%

Risk-free interest rate

 

4.39

%  

4.26

%

Expected life

 

6.08 years

 

6.08 years

Dividend

 

0

%  

0

%

Schedule of share-based compensation expense

    

2025

    

2024

Administration

$

737

 

$

910

Research and development

431

 

471

Commercial activities

183

 

131

Total

$

1,351

 

$

1,512